About
Carestream Health, Inc.:
Carestream
Health, Inc., is an internationally successful company providing
medical and dental imaging systems and information technology
solutions; molecular imaging systems; and non-destructive
testing products to a broad base of customers around the
world.
Onex Corporation, Toronto, Canada, acquired the Health Group
of Eastman Kodak Company in a multi-billion-dollar transaction
in May 2007. Upon closing, the business began operating
as a standalone entity (i.e., Carestream Health, Inc.) within
the Onex family of companies.
Today,
Carestream Health, headquartered in Rochester, N.Y., has
approximately 7,300 employees serving tens of thousands
of customers in more than 150 countries.
About
iCAD, Inc.:
iCAD,
Inc. is an industry-leading provider of advanced image
analysis and workflow solutions that enable healthcare
professionals to better serve patients by identifying
pathologies and pinpointing cancer earlier. iCAD offers
a comprehensive range of high-performance, upgradeable
Computer-Aided Detection (CAD) systems and workflow solutions
for mammography (film-based, digital radiography (DR)
and computed radiography (CR), Magnetic Resonance Imaging
(MRI), and Computed Tomography (CT). Since receiving FDA
approval for the Company’s first breast cancer detection
product in 2002, over 3,100 iCAD systems have been placed
in healthcare practices worldwide. iCAD’s solutions
aid in the early detection of the most prevalent cancers
including breast, colon, prostate and in the future, lung
cancer. For more information, call (877) iCADnow.
iCAD
is the world's largest CAD company. We have an industry-leading
Research and Development team giving iCAD a strong base
of intellectual property as is evident in the 22 CAD-related
patents awarded and the additional 20 patents in process.
About
Medicsight PLC:
From
its headquarters in the UK and supported by it's commercial
offices in the USA, Japan and China, Medicsight PLC develops
CT scan image analysis tools. Using image processing algorithms
Medicsight has created technology which can be used to
assist in the early detection and management of disease.
Medicsight
PLC is now at the forefront of one of the highest growth
and development sectors of medical imaging: Computer-Aided
Detection (CAD). Its market-leading CAD software products
have been rigorously tested on one of the world’s
largest and most population-diverse, optically verified
CT scan databases. The unique software is designed to
improve detection and analysis of suspicious pathology,
such as colorectal polyps and lung nodules, which may
be precursors to colonic and lung cancers.
Since
its inception in 2000, Medicsight has developed close
and lasting relationships with some of the world’s
most respected clinicians, providing the company with
a wealth of clinical expertise and dedicated research
to support.
The
company also collaborates with a number of leading academic
institutions and clinical research programmes around the
globe, to ensure its products are designed and validated
to the highest possible standards using diverse and independent
data sources.
